A Study to Compare MitoQ and Placebo to Treat Non-alcoholic Fatty Liver Disease (NAFLD)
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether a new medicine, called mitoquinone, will
reduce raised liver enzymes due to NAFLD and to see if it is safe.